Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D-Reference-Cited by-同舟云学术

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D

Published:2021-07-07 Issue:7 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hara Takashi¹,Hijikata Yasukazu¹,Matsubara Yukiko²,Watanabe Norio³

Affiliation:

1. Department of Healthcare Epidemiology; Kyoto University Graduate School of Medicine/School of Public Health; Kyoto Japan

2. Department of Nephrology; Hiroshima University Hospital; Hiroshima Japan

3. Department of Psychiatry; Soseikai General Hospital; Kyoto Japan

Publisher

Wiley

Subject

Pharmacology (medical)

Reference155 articles.

1. Bone mineral density and bone turnover marker changes with sequential abaloparatide/alendronate: Results of ACTIVExtend [abstract no: MO0655];Bilezikian;Journal of Bone & Mineral Research,2017

2. Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial;Bilezikian;Current Medical Research & Opinion,2019

3. Abaloparatide-SC has minimal effects in subjects with mild or moderate renal impairment: Results from the ACTIVE trial [abstract no: SU0282];Bilezikian;Journal of Bone & Mineral Research,2016

4. Effects of abaloparatide-sc on fractures and bone mineral density in subgroups of postmenopausal women with osteoporosis and varying baseline risk factors;Cosman;Journal of Bone & Mineral Research,2017

5. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial [Erratum in: JAMA. 2017 Jan 24;317(4):442; PMID: 28118431];Miller;JAMA,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological interventions for bone health in people with epilepsy;Cochrane Database of Systematic Reviews;2024-01-10

2. Bone Turnover Markers: Basic Biology to Clinical Applications;Endocrine Reviews;2022-12-13

3. Effectiveness of Pharmacological Interventions Versus Placebo or No Treatment for Osteoporosis in Patients With CKD Stages 3-5D: Editorial Summary of a Cochrane Review;American Journal of Kidney Diseases;2022-12

4. Management of fracture risk in CKD—traditional and novel approaches;Clinical Kidney Journal;2022-10-22

5. EXTENSIVE EXPERTISE IN ENDOCRINOLOGY: Osteoporosis management;European Journal of Endocrinology;2022-09-12